Efficacy of agomelatine on anxiety symptoms and functional impairment in adult patients with generalized anxiety disorder

被引:0
|
作者
Khoo, J. P. [1 ]
Picarel-Blanchot, F. [2 ]
Olivier, V. [3 ]
Dan, S. [4 ]
机构
[1] Toowong Specialist Clin, Level 2-54 Jephson St, Toowong, Qld 4066, Australia
[2] Servier Med Affairs Internal Med & Neuropsychiat, Suresnes, France
[3] Inst Rech Int Servier, Ctr Therapeut Innovat, 50 Rue Carnot, F-92284 Suresnes, France
[4] Groote Schuur Hosp, J Block Anzio Rd Observ, ZA-7925 Cape Town, South Africa
关键词
D O I
10.1016/j.euroneuro.2020.09.082
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
P.096
引用
收藏
页码:S60 / S60
页数:1
相关论文
共 50 条
  • [1] Efficacy of agomelatine for anxiety symptoms in adult patients with major depressive disorder
    Stein, D.
    Chimits, D.
    Picarel-Blanchot, F.
    Khoo, J. P.
    [J]. EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2020, 40 : S59 - S60
  • [2] EFFICACY OF THE ANTIDEPRESSANT AGOMELATINE FOR THE ANXIETY SYMPTOMS OF DEPRESSION IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Stein, D. J.
    Castle, D. J.
    Kennedy, S. H.
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2012, 46 : 31 - 32
  • [3] Agomelatine in treating generalized anxiety disorder
    Demyttenaere, Koen
    [J]. EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2014, 23 (06) : 857 - 864
  • [4] Agomelatine for the treatment of generalized anxiety disorder
    Buoli, Massimiliano
    Grassi, Silvia
    Serati, Marta
    Altamura, A. Carlo
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2017, 18 (13) : 1373 - 1379
  • [5] Agomelatine improves symptoms of generalised anxiety disorder
    Baldwin, David S.
    Lopes, Antonio T.
    [J]. EVIDENCE-BASED MENTAL HEALTH, 2009, 12 (02) : 54 - 54
  • [6] Efficacy of Agomelatine 25–50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
    Dan J. Stein
    Jon-Paul Khoo
    Françoise Picarel-Blanchot
    Valérie Olivier
    Michael Van Ameringen
    [J]. Advances in Therapy, 2021, 38 : 1567 - 1583
  • [7] Impairment in generalized anxiety disorder
    Olfson, M
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2000, 157 (12): : 2060 - 2061
  • [8] Pooled analysis of venlafaxine XR efficacy on somatic and psychic symptoms of anxiety in patients with generalized anxiety disorder
    Meoni, P
    Hackett, D
    Lader, M
    [J]. DEPRESSION AND ANXIETY, 2004, 19 (02) : 127 - 132
  • [9] Efficacy of Agomelatine 25-50 mg for the Treatment of Anxious Symptoms and Functional Impairment in Generalized Anxiety Disorder: A Meta-Analysis of Three Placebo-Controlled Studies
    Stein, Dan J.
    Khoo, Jon-Paul
    Picarel-Blanchot, Francoise
    Olivier, Valerie
    Van Ameringen, Michael
    [J]. ADVANCES IN THERAPY, 2021, 38 (03) : 1567 - 1583
  • [10] Anxiety symptoms and generalized anxiety disorder in the elderly: A review
    Alwahhabi, F
    [J]. HARVARD REVIEW OF PSYCHIATRY, 2003, 11 (04) : 180 - 193